Medtronic admits its results will be below expectations in face of fierce competition in ICD (implantable cardioverter defibrillator) market
This article was originally published in Clinica
Executive Summary
Medtronic has conceded that its first-quarter results and earnings per share for 1998 will be below its own expectations and will not meet analysts' published estimates. The company's share price fell almost 10% to $52.50 on the news before recovering to around $56 a share.